Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 43
- Q1 2025, −3 vs. previous quarter
- 13F value
- $3.10M
- Reported value at the end of Q1 2025
- Superinvestors holding
- 0
- At the end of Q1 2025
Superinvestors holding AXDX, Q1 2025
No superinvestor reported holding AXDX at the end of Q1 2025.
Latest insider trades
Open-market purchases and sales by Accelerate Diagnostics, Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | Phillips JackChief Executive Officer | SSale | −25.3K | $0.65 | −$16.5K | −11.7%191.4K after | |
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | Mertz Larry MichaelChief Technology Officer | SSale | −1.52K | $0.65 | −$989.95 | −1.8%84.8K after | |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Patience DavidChief Financial Officer | SSale | −6.82K | $0.71 | −$4.84K | −9.5%64.6K after | |
| Feb 27, 2025 (view filing) | Feb 26 | 1 day | Patience DavidChief Financial Officer | SSale | −535 | $1.09 | −$583.15 | −1.0%51.4K after | |
| Feb 4, 2025 (view filing) | Feb 3 | 1 day | Phillips JackChief Executive Officer | SSale | −485 | $1.35 | −$654.75 | −0.3%163.4K after | |
| Dec 3, 2024 (view filing) | Dec 3 | Same day | Patience JohnDirector | PPurchase | +200.0K | $1.57 | +$314.0K | +44.1%653.2K after | |
| Dec 3, 2024 (view filing) | Dec 3 | Same day | Schuler Jack WDirector, 10% Owner | SSale | −200.0K | $1.57 | −$314.0K | −2.4%8.31M after | |
| May 21, 2024 (view filing) | May 20 | 1 day | Mertz Larry MichaelChief Technology Officer | SSale | −361 | $0.88 | −$317.68 | −0.4%82.0K after | 2 lots |
| Apr 18, 2024 (view filing) | Apr 17 | 1 day | Phillips JackChief Executive Officer | SSale | −26.7K | $0.78 | −$20.9K | −14.1%162.9K after | 10b5-1 |
| Apr 16, 2024 (view filing) | Apr 12 | 4 days | Phillips JackChief Executive Officer | SSale | −26.5K | $0.86 | −$22.8K | −17.0%129.7K after | 10b5-1 |
Top 10 13F holders, Q1 2025
The largest institutional positions in Accelerate Diagnostics, Inc at the end of Q1 2025; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,879,227 | $1.32M | 0.04% | −198,773−9.6% | Reduced |
| Griffin Asset Management, Inc. | 853,036 | $598.0K | 0.07% | −150,545−15.0% | Reduced |
| Vanguard Group Inc | 478,093 | $335.1K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 325,239 | $228.0K | 0.20% | 00.0% | Unchanged |
| Lido Advisors, LLC | 163,161 | $114.4K | 0.00% | +163,161 | New |
| Geode Capital Management, LLC | 142,518 | $99.9K | 0.00% | +6,786+5.0% | Added |
| Spears Abacus Advisors LLC | 114,523 | $80.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 64,200 | $45.0K | 0.00% | −42,862−40.0% | Reduced |
| TCI Wealth Advisors, Inc. | 55,586 | $39.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 55,268 | $38.7K | 0.00% | +25,616+86.4% | Added |